Cite
pH-Triggered Transformable Peptide Nanocarriers Extend Drug Retention for Breast Cancer Combination Therapy.
MLA
Yuan, Xiaomeng, et al. “PH-Triggered Transformable Peptide Nanocarriers Extend Drug Retention for Breast Cancer Combination Therapy.” Advanced Healthcare Materials, vol. 13, no. 18, July 2024, p. e2400031. EBSCOhost, https://doi.org/10.1002/adhm.202400031.
APA
Yuan, X., Liu, X., Li, H., Peng, S., Huang, H., Yu, Z., Chen, L., Liu, X., & Bai, J. (2024). pH-Triggered Transformable Peptide Nanocarriers Extend Drug Retention for Breast Cancer Combination Therapy. Advanced Healthcare Materials, 13(18), e2400031. https://doi.org/10.1002/adhm.202400031
Chicago
Yuan, Xiaomeng, Xiaoying Liu, Hongjie Li, Shan Peng, Haiqin Huang, Zhe Yu, Limei Chen, Xinlu Liu, and Jingkun Bai. 2024. “PH-Triggered Transformable Peptide Nanocarriers Extend Drug Retention for Breast Cancer Combination Therapy.” Advanced Healthcare Materials 13 (18): e2400031. doi:10.1002/adhm.202400031.